WallStreetZenWallStreetZen

NASDAQ: AVXL
Anavex Life Sciences Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AVXL earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$43.2M
Current Profit Margin
0%

AVXL Return on Equity

Current Company
-30.3%
Current Industry
-63.5%
Current Market
188%
AVXL's Return on Equity (-30.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AVXL announces earnings.

AVXL Return on Assets

Current Company
-27.9%
Current Industry
2.9%
AVXL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AVXL Return on Capital Employed

Current Company
-31.75%
Current Industry
19.5%
AVXL has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AVXL vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AVXL$0.00-$43.04M-$43.16MN/AN/A
VRCA$5.12M-$62.20M-$67.00M-34.65%N/A
ERAS$0.00-$121.31M-$125.04MN/AN/A
XOMA$4.76M-$39.24M-$46.30M-2.13%N/A
ADAP$60.28M-$102.70M-$113.87M+0.26%N/A
View Top Biotech Stocks

AVXL earnings dates

Next earnings date
May 22, 2024

Anavex Life Sciences Earnings & Revenue FAQ

What were AVXL's earnings last quarter?

On Invalid Date, Anavex Life Sciences (NASDAQ: AVXL) reported Q4 2023 earnings per share (EPS) of -$0.11, up 35.29% year over year. Total Anavex Life Sciences earnings for the quarter were -$8.62 million. In the same quarter last year, Anavex Life Sciences's earnings per share (EPS) was -$0.17.

If you're new to stock investing, here's how to buy Anavex Life Sciences stock.

What was AVXL's earnings growth in the past year?

As of Q2 2024, Anavex Life Sciences's earnings has grown year over year. Anavex Life Sciences's earnings in the past year totalled -$43.16 million.

What is AVXL's earnings date?

Anavex Life Sciences's earnings date is Invalid Date. Add AVXL to your watchlist to be reminded of AVXL's next earnings announcement.

What was AVXL's revenue last quarter?

On Invalid Date, Anavex Life Sciences (NASDAQ: AVXL) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Anavex Life Sciences's revenue was $0.00.

What was AVXL's revenue growth in the past year?

As of Q2 2024, Anavex Life Sciences's revenue has grown null year over year. Anavex Life Sciences's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.